Fig. 1From: Idiopathic non-histaminergic acquired angioedema: a case series and discussion of published clinical trialsMedication use during treatment with omalizumab in patient 1. Red solid line Omalizumab injections; black solid line Prednisone intake; blue solid line Cetirizine intake; green solid line Ketotifen intake. Average doses of AH and oral glucocorticoids were calculated for every month in the past two and a half yearsBack to article page